ReShape Lifesciences Inc.

NASDAQ:RSLS  
0.62
+0.02 (+3.95%)
Debt Financing / Related

ReShape Lifesciences Enters Into Warrant Exercise Transaction For $2.5 Million In Gross Proceeds

Published: 06/17/2022 12:42 GMT
ReShape Lifesciences Inc. (RSLS) - Reshape Lifesciences Enters Into Warrant Exercise Transaction for $2.5 Million in Gross Proceeds.
Reshape Lifesciences-agreement With Existing Accredited Investor to Exercise Outstanding Warrants to Purchase Up to 3.7 Million Shares of Common Stock.
Reshape Lifesciences-in Connection, Agreed to Reduce Exercise Price of 3.7 Million Exercised Warrants and 1.6 Million Remaining Unexercised Warrants to $0.6665.